* Molecular Templates Inc MTEM.OQ MTEM.O is expected
to show a
fall in quarterly revenue when it reports results on May 10
(estimated).
* The Austin Texas-based company is expected to report a
73.5% decrease in revenue to $2.25 million from $8.49 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Molecular Templates
Inc
is for a loss of 28 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 7.0%
in the last three months.
* Wall Street's median 12-month price target for Molecular
Templates Inc is $10.5, above its last closing price of $0.45.
This summary was machine generated May 9 at 02:06 GMT. All
figures in US dollars unless otherwise stated